Patent · US Active

Bispecific chimeric antigen receptors and encoding polynucleotides thereof

US9447194B2 · kind B2 · utility

70Cited by
2References
28Claims
0Family size

Assignee

Inventor

Key dates

Filing dateFeb 13, 2013
Grant dateSep 20, 2016
Priority date
Expiry dateFeb 13, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is directed to a bispecific chimeric antigen receptor, comprising: (a) at least two antigen-specific targeting regions; (b) an extracellular spacer domain; (c) a transmembrane domain; (d) at least one co-stimulatory domain; and (e) an intracellular signaling domain, wherein each antigen-specific targeting region comprises an antigen-specific single chain Fv (scFv) fragment, and binds a different antigen, and wherein the bispecific chimeric antigen receptor is co-expressed with a therapeutic control. The invention also provides methods and uses of the bispecific chimeric antigen receptors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.